热门
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
文献类型:期刊论文
作者 | Zhang, Ge2; Guo, Baosheng2; Wu, Heng2; Tang, Tao2; Zhang, Bao-Ting2,3; Zheng, Lizhen2; He, Yixin2; Yang, Zhijun4; Pan, Xiaohua5; Chow, Heelum6 |
刊名 | NATURE MEDICINE |
出版日期 | 2012-02 |
卷号 | 18期号:2页码:307-314 |
ISSN号 | 1078-8956 |
DOI | 10.1038/nm.2617 |
文献子类 | Article |
英文摘要 | Metabolic skeletal disorders associated with impaired bone formation are a major clinical challenge. One approach to treat these defects is to silence bone-formation-inhibitory genes by small interference RNAs (siRNAs) in osteogenic-lineage cells that occupy the niche surrounding the bone-formation surfaces. We developed a targeting system involving dioleoyl trimethylammonium propane (DOTAP)-based cationic liposomes attached to six repetitive sequences of aspartate, serine, serine ((AspSerSer)(6)) for delivering siRNAs specifically to bone-formation surfaces. Using this system, we encapsulated an osteogenic siRNA that targets casein kinase-2 interacting protein-1 (encoded by Plekho1, also known as Plekho1). In vivo systemic delivery of Plekho1 siRNA in rats using our system resulted in the selective enrichment of the siRNAs in osteogenic cells and the subsequent depletion of Plekho1. A bioimaging analysis further showed that this approach markedly promoted bone formation, enhanced the bone micro-architecture and increased the bone mass in both healthy and osteoporotic rats. These results indicate (AspSerSer)(6)-liposome as a promising targeted delivery system for RNA interference- based bone anabolic therapy. |
WOS关键词 | PARATHYROID-HORMONE ; POSTMENOPAUSAL WOMEN ; OSTEOPOROSIS ; THERAPEUTICS ; ALENDRONATE ; COMBINATION ; DEPOSITION ; FRACTURES ; CULTURES ; DOMAINS |
资助项目 | Chinese National Basic Research Programs[2011CB910602] ; Hong Kong Competitive Earmarked Research Grant[CUHK479111] ; Hong Kong Competitive Earmarked Research Grant[473011] ; Faculty of Medicine of the Chinese University of Hong Kong[2041478] ; Faculty of Medicine of the Chinese University of Hong Kong[2041525] ; Hong Kong Baptist University[31-08-089] ; Chinese National Natural Science Foundation[30830029] ; National Key Technologies Research and Development Program for New Drugs[2009ZX09503-002] |
WOS研究方向 | Biochemistry & Molecular Biology ; Cell Biology ; Research & Experimental Medicine |
语种 | 英语 |
出版者 | NATURE PUBLISHING GROUP |
WOS记录号 | WOS:000300140300048 |
源URL | [http://119.78.100.183/handle/2S10ELR8/278204] |
专题 | 药物制剂研究中心 |
通讯作者 | Qin, Ling |
作者单位 | 1.Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China; 2.Chinese Univ Hong Kong, Musculoskeletal Res Lab, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; 3.Chinese Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; 4.Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; 5.Ji Nan Univ, Dept Orthoped, Hosp Med Coll 2, Shenzhen Peoples Hosp, Shenzhen, Peoples R China; 6.Chinese Univ Hong Kong, Sch Pharm, Hong Kong, Hong Kong, Peoples R China; 7.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Delivery Syst, Shanghai 200031, Peoples R China; 8.Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; 9.Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China; 10.Jinan Univ, Biomed Res & Dev Ctr, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; |
推荐引用方式 GB/T 7714 | Zhang, Ge,Guo, Baosheng,Wu, Heng,et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy[J]. NATURE MEDICINE,2012,18(2):307-314. |
APA | Zhang, Ge.,Guo, Baosheng.,Wu, Heng.,Tang, Tao.,Zhang, Bao-Ting.,...&Qin, Ling.(2012).A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy.NATURE MEDICINE,18(2),307-314. |
MLA | Zhang, Ge,et al."A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy".NATURE MEDICINE 18.2(2012):307-314. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。